NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $21,000 | -60.4% | 11,238 | +0.8% | 0.00% | – |
Q4 2021 | $53,000 | -53.9% | 11,151 | -29.6% | 0.00% | – |
Q3 2021 | $115,000 | -11.5% | 15,843 | +12.6% | 0.00% | – |
Q2 2021 | $130,000 | -67.4% | 14,071 | -41.4% | 0.00% | – |
Q2 2020 | $399,000 | +60.2% | 24,005 | +9.9% | 0.00% | – |
Q1 2020 | $249,000 | – | 21,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |